UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 116.

Wenger, R H; Katschinski, D M (2016). The Three "Musketairs" – Lasker Prize 2016 goes to the protagonists of hypoxia research. Hypoxia, 2016(4):101-162.

Spescha, R D; Klohs, J; Semerano, A; Giacalone, G; Derungs, R S; Reiner, M F; Rodriguez Gutierrez, D; Mendez-Carmona, N; Glanzmann, M; Savarese, G; Kränkel, N; Akhmedov, A; Keller, S; Mocharla, P; Kaufmann, M R; Wenger, R H; Vogel, J; Kulic, L; Nitsch, R M; Beer, J H; Peruzzotti-Jametti, L; Sessa, Maria; Lüscher, Thomas F; Camici, G G (2015). Post-ischaemic silencing of p66Shc reduces ischaemia/reperfusion brain injury and its expression correlates to clinical outcome in stroke. European Heart Journal, 36(25):1590-1600.

Lelli, A; Nolan, K A; Santambrogio, S; Gonçalves, Ana Filipa; Schönenberger, Miriam J; Guinot, A; Frew, Ian J; Marti, Hugo H; Hoogewijs, D; Wenger, R H (2015). Induction of long noncoding RNA MALAT1 in hypoxic mice. Hypoxia, (3):45-52.

Hurtado-Carneiro, V; Roncero, I; Egger, S; Wenger, R H; Blazquez, E; Sanz, C; Alvarez, E (2014). PAS Kinase Is a Nutrient and Energy Sensor in Hypothalamic Areas Required for the Normal Function of AMPK and mTOR/S6K1. Molecular Neurobiology, 50(2):314-326.

Kaufmann, M R; Barth, S; Konietzko, U; Wu, Bei; Egger, Sascha; Kunze, Reiner; Marti, Hugo H; Hick, Meike; Müller, Ulrike; Camenisch, G; Wenger, R H (2013). Dysregulation of Hypoxia-Inducible Factor by Presenilin/ Gamma-Secretase Loss-of-Function Mutations. Journal of Neuroscience, 33(5):1915-1926.

Perrotta, S; Stiehl, D P; Punzo, F; Scianguetta, S; Borriello, A; Bencivenga, D; Casale, M; Nobili, B; Fasoli, S; Balduzzi, A; Cro, L; Nytko, K J; Wenger, R H; Della Ragione, F (2013). Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. Haematologica:1-34.

Kurtz, A; Wenger, R H; Eckardt, Kai-Uwe (2013). Hematopoiesis and the Kidney. In: Alpern, Robert J; Caplan, Michael J; Moe, Orson W. Seldin and Giebisch's THE KIDNEY Physiology and Pathophysiology. USA: Elsevier, 3087-3124.

Crucet, M; Wuest, Sophia J A; Spielmann, P; Luescher, T F; Wenger, R H; Matter, C M (2013). Hypoxia enhances lipid uptake in macrophages: Role of the scavenger receptors Lox1, SRA, and CD36. Atherosclerosis, 229(1):110-117.

Stiehl, D P; Bordoli, M R; Abreu-Rodríguez, I; Wollenick, K; Schraml, P; Gradin, K; Poellinger, L; Kristiansen, G; Wenger, R H (2012). Non-canonical HIF-2alpha function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene, 31(18):2283-2297.

Nytko, K J; Stiehl, D P; Wenger, R H (2012). PHD oxygen sensor function and antioxidants. In: Pastorekova, Silvia; Kopacek, Juraj. Tumor Hypoxia: Molecular Mechanisms and Clinical Implications. Frankfurt am Main: PETER LANG; VEDA, 127-155.

Wollenick, K; Hu, J; Kristiansen, G; Schraml, P; Rehrauer, H; Berchner-Pfannschmidt, U; Fandrey, J; Wenger, R H; Stiehl, D P (2012). Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling. Nucleic Acids Research, 40(5):1928-1943.

Dimas, Y; Camenisch, G; Wenger, R H; Wasserman, Wyeth; et al (2012). The transcription factor encyclopedia. Genome Biology, 13(3):R24.

Sharma, A; Bode, B; Wenger, R H; Lehmann, K; Sartori, A A; Moch, H; Knuth, A; von Boehmer, L; van den Broek, Maries (2011). Gamma-radiation promotes immunological recognition of cancer cells through increased expression of cancer-testis antigens in vitro and in vivo. PLoS ONE, 6(11):e28217.

Luehty, A; Stenner, F; Lohri, C; Muller, C; Samaras, P; Steiner, R; van den Broek, Maries; Mischo, A; Renner, C; Knuth, A; Ruegg, C; Wenger, R H; Zweifel, M (2011). Autologous Stem Cell Transplantation: Leukapheresis Product has Anti-angiogenic Effects In Vivo Correlating with Neutrophil-derived VEGFR1. Anticancer Research, 31(10):3115-3124.

Wenger, R H; Kurtz, A (2011). Erythropoietin. Comprehensive Physiology, 1(4):1759-1794.

Wildhaber, R A; Verrey, F; Wenger, R H (2011). A graphical simulation software for instruction in cardiovascular mechanics physiology. BioMedical Engineering OnLine, 10:8.

Bordoli, M R; Stiehl, D P; Borsig, L; Kristiansen, G; Hausladen, S; Schraml, P; Wenger, R H; Camenisch, G (2011). Prolyl-4-hydroxylase PHD2- and hypoxia-inducible factor 2-dependent regulation of amphiregulin contributes to breast tumorigenesis. Oncogene, 30(5):548-560.

Schläfli, P; Tröger, J; Eckhardt, K; Borter, E; Spielmann, P; Wenger, R H (2011). Substrate preference and phosphatidylinositol monophosphate inhibition of the catalytic domain of the PAS kinase PASKIN. FEBS Journal, 278(10):1757-1768.

Hasgall, P A; Hoogewijs, D; Faza, M B; Panse, V G; Wenger, R H; Camenisch, G (2011). The putative RNA helicase HELZ promotes cell proliferation, translation initiation and ribosomal protein S6 phosphorylation. PLoS ONE, 6(7):e22107.

Nytko, K J; Nobuyo, M; Schlaefli, P; Spielmann, P; Wenger, R H; Stiehl, D P (2011). Vitamin C is dispensable for oxygen sensing in vivo. Blood, 117(20):5485-5493.

Wenger, R H; Hoogewijs, D (2010). Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells. American Journal of Physiology: Renal Physiology, 298(6):F1287-F1296.

Wenger, R H; Camenisch, G; Stiehl, D P; Katschinski, D M (2009). HIF Prolyl-4-hydroxylase Interacting Proteins: Consequences for Drug Targeting. Current Pharmaceutical Design, 15(33):3886-3894.

Barth, S; Edlich, F; Berchner-Pfannschmidt, U; Gneuss, S; Jahreis, G; Hasgall, P A; Fandrey, J; Wenger, R H; Camenisch, G (2009). HIF Prolyl-4-Hydroxylase PHD2 protein abundance depends on integral membrane-anchoring of FKBP38. Journal of Biological Chemistry, 284(34):23046-23058.

Lehmann, S; Stiehl, D P; Honer, M; Dominietto, M; Keist, R; Kotevic, I; Wollenick, K; Ametamey, S; Wenger, R H; Rudin, M (2009). Longitudinal and multimodal in vivo imaging of tumor hypoxia and its downstream molecular events. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(33):14004-14009.

Balamurugan, K; Luu, V D; Kaufmann, M R; Hofmann, V S; Boysen, G; Barth, S; Bordoli, M R; Stiehl, D P; Moch, H; Schraml, P; Wenger, R H; Camenisch, G (2009). Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response. Oncogene:1-12.

Kurowska-Stolarska, M; Distler, J H; Jüngel, A; Rudnicka, W; Neumann, E; Pap, T; Wenger, R H; Michel, B A; Müller-Ladner, U; Gay, R E; Maslinski, W; Gay, S; Distler, O (2009). Inhibitor of DNA binding/differentiation 2 induced by hypoxia promotes synovial fibroblast-dependent osteoclastogenesis. Arthritis and Rheumatism, 60(12):3663-3675.

Ebbesen, P; Pettersen, E O; Gorr, T A; Jobst, G; Williams, K; Kieninger, J; Wenger, R H; Pastorekova, S; Dubois, L; Lambin, P; Wouters, B G; Van den Beucken, T; Beucken, D; Supuran, C T; Poellinger, L; Ratcliffe, P; Kanopka, A; Görlach, A; Gassmann, M; Harris, A L; Maxwell, P; Scozzafava, A (2009). Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies. Journal of Enzyme Inhibition and Medicinal Chemistry, 24(S1):1-39.

Schlaefli, P; Borter, E; Spielmann, P; Wenger, R H (2009). The PAS-domain kinase PASKIN: a new sensor in energy homeostasis. Cellular and Molecular Life Sciences, 66(5):876-883.

Wirthner, R; Wrann, S; Balamurugan, K; Wenger, R H; Stiehl, D P (2008). Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1-alpha-deficient mouse embryonic fibroblasts. Carcinogenesis, 29(12):2306-2316.

Wirthner, R; Balamurugan, K; Stiehl, D P; Barth, S; Spielmann, P; Oehme, F; Flamme, I; Katschinski, D M; Wenger, R H; Camenisch, G (2007). Determination and modulation of prolyl-4-hydroxylase domain oxygen sensor activity. Methods in Enzymology, 435:43-60.

Borter, E; Niessen, M; Zuellig, R; Spinas, G A; Spielmann, P; Camenisch, G; Wenger, R H (2007). Glucose-stimulated insulin production in mice deficient for the PAS kinase PASKIN. Diabetes, 56(1):113-117.

Ameri, K; Hammond, E M; Culmsee, C; Raida, M; Katschinski, D M; Wenger, R H; Wagner, E; Davis, R J; Hai, T; Denko, N; Harris, A L (2007). Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene, 26(2):284-289.

Milosevic, J; Maisel, M; Wegner, F; Leuchtenberger, J; Wenger, R H; Gerlach, M; Storch, A; Schwarz, J (2007). Lack of hypoxia-inducible factor-1 alpha impairs midbrain neural precursor cells involving vascular endothelial growth factor signaling. Journal of Neuroscience, 27(2):412-421.

Eckhardt, K; Troger, J; Reissmann, J; Katschinski, D M; Wagner, K F; Stengel, P J; Paasch, U; Hunziker, P; Borter, E; Barth, S; Schlafli, P; Spielmann, P; Stiehl, D P; Camenisch, G; Wenger, R H (2007). Male germ cell expression of the PAS domain kinase PASKIN and its novel target eukaryotic translation elongation factor eEF1A1. Cellular Physiology and Biochemistry, 20(1-4):227-240.

Köditz, J; Nesper, J; Wottawa, M; Stiehl, D P; Camenisch, G; Franke, C; Myllyharju, J; Wenger, R H; Katschinski, D M (2007). Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor. Blood, 110(10):3610-3617.

Nytko, K J; Spielmann, P; Camenisch, G; Wenger, R H; Stiehl, D P (2007). Regulated Function of the Prolyl-4-Hydroxylase Domain (PHD) Oxygen Sensor Proteins. Antioxidants & Redox Signaling, 9(9):1329-1338.

Barth, S; Nesper, J; Hasgall, P A; Wirthner, R; Nytko, K J; Edlich, F; Katschinski, D M; Stiehl, D P; Wenger, R H; Camenisch, G (2007). The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability. Molecular and Cellular Biology, 27(10):3758-3768.

Rassler, B; Marx, G; Reissig, C; Rohling, M A; Tannapfel, A; Wenger, R H; Zimmer, H G (2007). Time course of hypoxia-induced lung injury in rats. Respiratory Physiology & Neurobiology, 159(1):45-54.

Lukashev, D; Klebanov, B; Kojima, H; Grinberg, A; Ohta, A; Berenfeld, L; Wenger, R H; Ohta, A; Sitkovsky, M (2006). Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. Journal of Immunology, 177(8):4962-4965.

Stiehl, D P; Wirthner, R; Köditz, J; Spielmann, P; Camenisch, G; Wenger, R H (2006). Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. Journal of Biological Chemistry, 281(33):23482-23491.

Wenger, R H (2006). Mitochondria: oxygen sinks rather than sensors? Medical Hypotheses, 66(2):380-383.

Hägele, S; Behnam, B; Borter, E; Wolfe, J; Paasch, U; Lukashev, D; Sitkovsky, M; Wenger, R H; Katschinski, D M (2006). TSGA10 prevents nuclear localization of the hypoxia-inducible factor (HIF)-1alpha. FEBS Letters, 580(15):3731-3738.

Martin, F; Linden, T; Katschinski, D M; Oehme, F; Flamme, I; Mukhopadhyay, C K; Eckhardt, K; Tröger, J; Barth, S; Camenisch, G; Wenger, R H (2005). Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood, 105(12):4613-4619.

Ibrahim, N O; Hahn, T; Franke, C; Stiehl, D P; Wirthner, R; Wenger, R H; Katschinski, D M (2005). Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors. Cancer Research, 65(23):11094-11100.

Wenger, R H; Stiehl, D P; Camenisch, G (2005). Integration of oxygen signaling at the consensus HRE. Science Signaling, 2005(306):re12.

Wenger, R H; Katschinski, D M (2005). The hypoxic testis and post-meiotic expression of PAS domain proteins. Seminars in Cell and Developmental Biology, 16(4-5):547-553.

Depping, R H; Hägele, S; Wagner, K F; Wiesner, R J; Camenisch, G; Wenger, R H; Katschinski, D M (2004). A dominant-negative isoform of hypoxia-inducible factor-1 alpha specifically expressed in human testis. Biology of Reproduction, 71(1):331-339.

Briest, W; Homagk, L; Baba, H A; Deten, A; Rassler, B; Tannapfel, A; Wagner, K F; Wenger, R H; Zimmer, H G (2004). Cardiac remodeling in erythropoietin-transgenic mice. Cellular Physiology and Biochemistry, 14(4-6):277-284.

Katschinski, D M; Le, L; Schindler, S G; Thomas, T; Voss, A K; Wenger, R H (2004). Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. Cellular Physiology and Biochemistry, 14(4-6):351-360.

Carrière, A; Carmona, M C; Fernandez, Y; Rigoulet, M; Wenger, R H; Pénicaud, L; Casteilla, L (2004). Mitochondrial reactive oxygen species control the transcription factor CHOP-10/GADD153 and adipocyte differentiation: a mechanism for hypoxia-dependent effect. Journal of Biological Chemistry, 279(39):40462-40469.

Deten, A; Shibata, J; Scholz, D; Briest, W; Wagner, K F; Wenger, R H; Zimmer, H G (2004). Norepinephrine-induced acute heart failure in transgenic mice overexpressing erythropoietin. Cardiovascular Research, 61(1):105-114.

Distler, J H W; Wenger, R H; Gassmann, M; Kurowska, M; Hirth, A K; Gay, S; Distler, O (2004). Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis and Rheumatism, 50(1):10-23.

Wenger, R H (2004). Sauerstoffhomöostase in Gewebe und Zelle: Wie Sauerstoffmangel die Genexpression reguliert. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie, 39(S1):S38-S43.

Hofer, T; Pohjanvirta, R; Spielmann, P; Viluksela, M; Buchmann, D P; Wenger, R H; Gassmann, M (2004). Simultaneous exposure of rats to dioxin and carbon monoxide reduces the xenobiotic but not the hypoxic response. Biological Chemistry, 385(3-4):291-294.

Crawford, R M; Jovanovic, S; Budas, G R; Davies, A M; Lad, H; Wenger, R H; Robertson, K A; Roy, D J; Ranki, H J; Jovanovic, A (2003). Chronic mild hypoxia protects heart-derived H9c2 cells against acute hypoxia/reoxygenation by regulating expression of the SUR2A subunit of the ATP-sensitive K+ channel. Journal of Biological Chemistry, 278(33):31444-31455.

Shibata, J H W; Hasegawa, J; Siemens, H J; Wolber, E; Dibbelt, L; Li, D; Katschinski, D M; Fandrey, J; Jelkmann, W; Gassmann, M; Wenger, R H; Wagner, K F (2003). Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood, 101(11):4416-4422.

Hofer, T; Wenger, R H; Kramer, M F; Ferreira, G C; Gassmann, M (2003). Hypoxic up-regulation of erythroid 5-aminolevulinate synthase. Blood, 101(1):348-350.

Linden, T; Wenger, R H (2003). Iron chelation, angiogenesis and tumor therapy. International Journal of Cancer, 106(3):458-459.

Kunz, M; Moeller, S; Koczan, D; Lorenz, P; Wenger, R H; Glocker, M O; Thiesen, H J; Gross, G; Ibrahim, S M (2003). Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. Journal of Biological Chemistry, 278(46):45651-45660.

Schäffer, L; Scheid, A; Spielmann, P; Breymann, C; Zimmermann, R; Meuli, M; Gassmann, M; Marti, H H; Wenger, R H (2003). Oxygen-regulated expression of TGF-beta 3, a growth factor involved in trophoblast differentiation. Placenta, 24(10):941-950.

Katschinski, D M; Marti, H H; Wagner, K F; Shibata, J; Eckhardt, K; Martin, F; Depping, R; Paasch, U; Gassmann, M; Ledermann, B; Desbaillets, I; Wenger, R H (2003). Targeted disruption of the mouse PAS domain serine/threonine kinase PASKIN. Molecular and Cellular Biology, 23(19):6780-6789.

Linden, T; Katschinski, D M; Eckhardt, K; Scheid, A; Pagel, H; Wenger, R H (2003). The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis. FASEB Journal, 17(6):761-763.

Gess, B; Hofbauer, K H; Wenger, R H; Lohaus, C; Meyer, H E; Kurtz, A (2003). The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. FEBS Journal, 270(10):2228-2235.

Unruh, A; Ressel, A; Mohamed, H G; Johnson, R S; Nadrowitz, R; Richter, E; Katschinski, D M; Wenger, R H (2003). The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene, 22(21):3213-3220.

Hofer, T; Desbaillets, I; Höpfl, G R; Wenger, R H; Gassmann, M (2002). Characterization of HIF-1 alpha overexpressing HeLa cells and implications for gene therapy. Comparative Biochemistry and Physiology - Part C: Toxicology & Pharmacology, 133(4):475-481.

Höpfl, G; Wenger, R H; Ziegler, U; Stallmach, T; Gardelle, O; Achermann, R H; Wergin, M; Kaser-Hotz, B; Saunders, H M; Williams, K J; Stratford, I J; Gassmann, M; Desbaillets, I (2002). Rescue of hypoxia-inducible factor-1alpha-deficient tumor growth by wild-type cells is independent of vascular endothelial growth factor. Cancer Research, 62(10):2962-2970.

Wenger, R H (2002). Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expression. FASEB Journal, 16(10):1151-1162.

Camenisch, G; Wenger, R H; Gassmann, M (2002). DNA-binding activity of hypoxia-inducible factors (HIFs). Methods in Molecular Biology, 196:117-129.

Katschinski, D M; Le, L; Heinrich, D; Wagner, K F; Hofer, T; Schindler, S G; Wenger, R H (2002). Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. Journal of Biological Chemistry, 277(11):9262-9267.

Marti, H H; Katschinski, D M; Wagner, K F; Schäffer, L; Stier, B; Wenger, R H (2002). Isoform-specific expression of hypoxia-inducible factor-1alpha during the late stages of mouse spermiogenesis. Molecular Endocrinology, 16(2):234-243.

Stiehl, D P; Jelkmann, W; Wenger, R H; Hellwig-Bürgel, T (2002). Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Letters, 512(1-3):157-162.

Scheid, A; Wenger, R H; Schäffer, L; Camenisch, I; Distler, O; Ferenc, A; Cristina, H G; Ryan, H E; Johnson, R S; Wagner, K F; Stauffer, U G; Bauer, C; Gassmann, M; Meuli, M (2002). Physiologically low oxygen concentrations in fetal skin regulate hypoxia-inducible factor 1 and transforming growth factor-beta3. FASEB Journal, 16(3):411-413.

Camenisch, G; Stroka, D M; Gassmann, M; Wenger, R H (2001). Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression. Pflügers Archiv: European Journal of Physiology (Pflugers Archiv), 443(2):240-249.

Hofer, T; Desbaillets, I; Höpfl, G; Gassmann, M; Wenger, R H (2001). Dissecting hypoxia-dependent and hypoxia-independent steps in the HIF-1alpha activation cascade: implications for HIF-1alpha gene therapy. FASEB Journal, 15(14):2715-2717.

Stroka, D M; Burkhardt, T; Desbaillets, I; Wenger, R H; Neil, D A; Bauer, C; Gassmann, M; Candinas, D (2001). HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB Journal, 15(13):2445-2453.

Chilov, D; Hofer, T; Bauer, C; Wenger, R H; Gassmann, M (2001). Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain. FASEB Journal, 15(14):2613-2622.

Jewell, U R; Kvietikova, I; Scheid, A; Bauer, C; Wenger, R H; Gassmann, M (2001). Induction of HIF-1alpha in response to hypoxia is instantaneous. FASEB Journal, 15(7):1312-1314.

Hofer, T; Spielmann, P; Stengel, P; Stier, B; Katschinski, D M; Desbaillets, I; Gassmann, M; Wenger, R H (2001). Mammalian PASKIN, a PAS-serine/threonine kinase related to bacterial oxygen sensors. Biochemical and Biophysical Research Communications (BBRC), 288(4):757-764.

Wenger, R H; Bauer, C (2001). Oxygen sensing: "hydroxy" translates "oxy". News in Physiological Sciences, 16(4):195-196.

Ruschitzka, F T; Wenger, R H; Stallmach, T; Quaschning, T; de Wit, C; Wagner, K; Labugger, R; Kelm, M; Noll, G; Rülicke, T; Shaw, S; Lindberg, R L; Rodenwaldt, B; Lutz, H; Bauer, C; Lüscher, T F; Gassmann, M (2000). Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 97(21):11609-11613.

Pavlicek, V; Marti, H H; Grad, S; Gibbs, J S; Kol, C; Wenger, R H; Gassmann, M; Kohl, J; Maly, F E; Oelz, O; Koller, E A; Schirlo, C (2000). Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema. European Journal of Applied Physiology, 61(6):497-503.

Görlach, A; Camenisch, G; Kvietikova, I; Vogt, L; Wenger, R H; Gassmann, M (2000). Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. Biochimica et Biophysica Acta, 1493(1-2):125-134.

Wanner, R M; Spielmann, P; Stroka, D M; Camenisch, G; Camenisch, I; Scheid, A; Houck, D R; Bauer, C; Gassmann, M; Wenger, R H (2000). Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation. Blood, 96(4):1558-1565.

Scheid, A; Meuli, M; Gassmann, M; Wenger, R H (2000). Genetically modified mouse models in studies on cutaneous wound healing. Experimental Physiology, 85(6):687-704.

Scheid, A; Wenger, R H; Christina, H; Camenisch, I; Ferenc, A; Stauffer, U G; Gassmann, M; Meuli, M (2000). Hypoxia-regulated gene expression in fetal wound regeneration and adult wound repair. Pediatric Surgery International, 16(4):232-236.

Wenger, R H (2000). Mammalian oxygen sensing, signalling and gene regulation. Journal of Experimental Biology, 203(Pt. 8):1253-1263.

Gassmann, M; Chilov, D; Wenger, R H (2000). Regulation of the hypoxia-inducible factor-1 alpha. ARNT is not necessary for hypoxic induction of HIF-1 alpha in the nucleus. In: Lahiri, S; Prabhaker, N; Forster, R. Oxygen Sensing: Molecule to Man. New York: Kluwer, 87-99.

Chilov, D; Camenisch, G; Kvietikova, I; Ziegler, U; Gassmann, M; Wenger, R H (1999). Induction and nuclear translocation of hypoxia-inducible factor-1 (HIF-1): heterodimerization with ARNT is not necessary for nuclear accumulation of HIF-1alpha. Journal of Cell Science, 112(Pt. 8):1203-1212.

Camenisch, G; Tini, M; Chilov, D; Kvietikova, I; Srinivas, V; Caro, J; Spielmann, P; Wenger, R H; Gassmann, M (1999). General applicability of chicken egg yolk antibodies: the performance of IgY immunoglobulins raised against the hypoxia-inducible factor 1alpha. FASEB Journal, 13(1):81-88.

Bichet, S; Wenger, R H; Camenisch, G; Rolfs, A; Ehleben, W; Porwol, T; Acker, H; Fandrey, J; Bauer, C; Gassmann, M (1999). Oxygen tension modulates beta-globin switching in embryoid bodies. FASEB Journal, 13(2):285-295.

Wenger, R H; Rolfs, A; Spielmann, P; Zimmermann, D R; Gassmann, M (1998). Mouse hypoxia-inducible factor-1alpha is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood, 91(9):3471-3480.

Iyer, N V; Kotch, L E; Agani, F; Leung, S W; Laughner, E; Wenger, R H; Gassmann, M; Gearhart, J D; Lawler, A M; Yu, A Y; Semenza, G L (1998). Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes and Development, 12(2):149-162.

Wenger, R H; Marti, H H; Bauer, C; Gassmann, M (1998). Optimal erythropoietin expression in human hepatoma cell lines requires activation of multiple signalling pathways. International Journal of Molecular Medicine, 2(3):317-324.

Wenger, R H; Kvietikova, I; Rolfs, A; Camenisch, G; Gassmann, M (1998). Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. FEBS Journal, 253(3):771-777.

Wenger, R H; Camenisch, G; Desbaillets, I; Chilov, D; Gassmann, M (1998). Up-regulation of hypoxia-inducible factor-1alpha is not sufficient for hypoxic/anoxic p53 induction. Cancer Research, 58(24):5678-5680.

Nielsen, P J; Lorenz, B; Müller, A M; Wenger, R H; Brombacher, F; Simon, M; von der Weid, T; Langhorne, W J; Mossmann, H; Köhler, G (1997). Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice. Blood, 89(3):1058-1067.

Marti, H H; Gassmann, M; Wenger, R H; Kvietikova, I; Morganti-Kossmann, M C; Kossmann, T; Trentz, O; Bauer, C (1997). Detection of erythropoietin in human liquor: intrinsic erythropoietin production in the brain. Kidney International, 51(2):416-418.

Liu, Y; Wenger, R H; Zhao, M; Nielsen, P J (1997). Distinct costimulatory molecules are required for the induction of effector and memory cytotoxic T lymphocytes. Journal of Experimental Medicine, 185(2):251-262.

Wenger, R H; Kvietikova, I; Rolfs, A; Gassmann, M; Marti, H H (1997). Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level. Kidney International, 51(2):560-563.

Wenger, R H; Gassmann, M (1997). Oxygen(es) and the hypoxia-inducible factor-1. Biological Chemistry, 378(7):609-616.

Gassmann, M; Kvietikova, I; Rolfs, A; Wenger, R H (1997). Oxygen- and dioxin-regulated gene expression in mouse hepatoma cells. Kidney International, 51(2):567-574.

Rolfs, A; Kvietikova, I; Gassmann, M; Wenger, R H (1997). Oxygen-regulated transferrin expression is mediated by hypoxia-inducible factor-1. Journal of Biological Chemistry:.-..

Kvietikova, I; Wenger, R H; Marti, H H; Gassmann, M (1997). The hypoxia-inducible factor-1 DNA recognition site is cAMP-responsive. Kidney International, 51(2):564-566.

Wenger, R H; Rolfs, A; Kvietikova, I; Spielmann, P; Zimmermann, D R; Gassmann, M (1997). The mouse gene for hypoxia-inducible factor-1alpha--genomic organization, expression and characterization of an alternative first exon and 5' flanking sequence. European Journal of Biochemistry, 246(1):155-165.

Wenger, R H; Marti, H H; Schuerer-Maly, C C; Kvietikova, I; Bauer, C; Gassmann, M; Maly, F E (1996). Hypoxic induction of gene expression in chronic granulomatous disease-derived B-cell lines: oxygen sensing is independent of the cytochrome b558-containing nicotinamide adenine dinucleotide phosphate oxidase. Blood, 87(2):756-761.

Camenisch, G; Gruber, M; Donoho, G; Van Sloun, P; Wenger, R H; Gassmann, M (1996). A polyoma-based episomal vector efficiently expresses exogenous genes in mouse embryonic stem cells. Nucleic Acids Research, 24(19):3707-3713.

Marti, H H; Wenger, R H; Rivas, L A; Straumann, U; Digicaylioglu, M; Henn, V; Yonekawa, Y; Bauer, C; Gassmann, M (1996). Erythropoietin gene expression in human, monkey and murine brain. European Journal of Neuroscience, 8(4):666-676.

Gradin, K; McGuire, J; Wenger, R H; Kvietikova, I; Whitelaw, M L; Toftgård, R; Tora, L; Gassmann, M; Poellinger, L (1996). Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Molecular and Cellular Biology, 16(10):5221-5231.

Wenger, R H; Gassmann, M (1996). Little difference. Nature, 380(6570):100.

Wenger, R H; Rolfs, A; Marti, H H; Guénet, J L; Gassmann, M (1996). Nucleotide sequence, chromosomal assignment and mRNA expression of mouse hypoxia-inducible factor-1 alpha. Biochemical and Biophysical Research Communications (BBRC), 223(1):54-59.

Gassmann, M; Fandrey, J; Bichet, S; Wartenberg, M; Marti, H H; Bauer, C; Wenger, R H; Acker, H (1996). Oxygen supply and oxygen-dependent gene expression in differentiating embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 93(7):2867-2872.

Wenger, R H; Kopf, M; Nitschke, L; Lamers, M C; Köhler, G; Nielsen, P J (1995). B-cell maturation in chimaeric mice deficient for the heat stable antigen (HSA/mouse CD24). Transgenic Research, 4(3):173-183.

Wenger, R H; Rolfs, A; Marti, H H; Bauer, C; Gassmann, M (1995). Hypoxia, a novel inducer of acute phase gene expression in a human hepatoma cell line. Journal of Biological Chemistry, 270(46):27865-27870.

Digicaylioglu, M; Bichet, S; Marti, H H; Wenger, R H; Rivas, L A; Bauer, C; Gassmann, M (1995). Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 92(9):3717-3720.

Wenger, R H; Gassmann, M (1995). Mitochondria contaminate databases. Trends in Genetics, 11(5):167-168.

Kvietikova, I; Wenger, R H; Marti, H H; Gassmann, M (1995). The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Research, 23(22):4542-4550.

This list was generated on Tue Jul 25 12:51:26 2017 CEST.